Fatty acid-rich hepatocellular carcinoma tissue

Fatty acid-rich hepatocellular carcinoma tissue, scientifically recognized as steatotic hepatocellular carcinoma (SHCC), is a distinct histological variant of primary liver cancer characterized by significant lipid accumulation (steatosis) within the tumor cells. This variant is strongly linked to metabolic risk factors such as obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD (Source: WHO Classification of Tumours; PubMed: 22434719). While the tissue itself is a pathological manifestation rather than a single druggable molecule, it represents a unique metabolic microenvironment where pathways like de novo lipogenesis and fatty acid uptake are highly active. Research indicates that SHCC may have a specific molecular profile, often involving the activation of the IL-6/JAK/STAT pathway and increased expression of lipid-regulating proteins (Source: PubMed: 27103231). Understanding this tissue type is critical for clinical diagnostics, as it must be differentiated from benign steatotic lesions, and it may influence the selection of metabolic-based therapeutic strategies in the future.

Other names

Steatotic hepatocellular carcinomaFatty hepatocellular carcinomaLipid-rich hepatocellular carcinomaSHCC

Not applicable as this refers to a histological tissue variant rather than a specific molecular target.